|
|
Post by ilovekauai on Apr 15, 2016 13:08:38 GMT -5
Well, over the years if there's one thing I've learned from this stock; is to expect the unexpected. I'm curious as to what unfolds next Tuesday at the CC. Such a wild ride this holding has been with more "thrills" in the future I suspect. Have a great weekend all. Aloha.
|
|
|
|
Post by bradleysbest on Apr 15, 2016 14:18:59 GMT -5
Why schedule next week's CC if they don't have any positive news to report? I think we get something & see a lil pop in price....
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Apr 15, 2016 14:34:31 GMT -5
@reverselo , I respectfully disagree, but I'll at least acknowledge that several factors could have been at play in June. An analyst upgraded recommendation followed the Jeffries conference where Matt Pfeffer presented. The analyst was Shaunak Deepak, who led the questioning. You can read the transcript at this link:
MannKind's (MNKD) Management Presents at Jefferies Global Healthcare Conference www.nasdaq.com/aspx/call-transcript.aspx?StoryId=3234406&Title=mannkind-s-mnkd-management-presents-at-jefferies-global-healthcare-conference-transcript-
Shareholders may recall that this was the conference where Matt announced that 54,000 sample packs had been shipped to Sanofi and that Sanofi had requested that more sample packs be manufactured. Matt also talked about four API having been selected for development in MannKind's pipeline, which had been mothballed for years following the second CRL from the FDA and was about to become operational again.
My point above was that if Matt provides specific guidance, it can lead to positive movement in analyst upgrades and Wall Street sentiment. Following this interview and Jeffries upgrade to Buy with a $9 price target, MNKD stock rallied from $5.15 to $7.23 in a few days' time.
---
I am of the opinion that next week's conference call will have the same effect and I am definitely expecting a rally to follow.
Its cool, we can agree to disagree. I am pretty confident I have this pegged right. MNKD stock rallied from 3.63 to 7.23 (it was even lower and higher including intraday) over about a months time. Take a look at the chart. The rally started way before 5.15. Deepak has an awful rating over time so lets be realistic he was not moving the needle almost a 100%. Even Adam F commented at the time that MNKD had people scared and they were covering. The stock was at all time lows and was perfect for the BOA covering to start taking place. Deepak definately kept it moving (as I mentioned in my earlier post but did not reference him by name) but those 9 million shares that were shorted and covered soon were shorted again into new hands and thus the price decline started. |
|
